Online citations, reference lists, and bibliographies.
← Back to Search

Well-Defined Poly(butyl Cyanoacrylate) Nanoparticles Via Miniemulsion Polymerization

M. Wu, C. Frochot, E. Dellacherie, E. Marie
Published 2009 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Summary: Despite the high reactivity of the monomer, nanoparticles with a hydrophobic core based on poly(butyl cyanoacrylate) and a hydrophilic shell based on poly(ethylene oxide) PEO were synthesized in one step by miniemulsion polymerization. Colloidal properties of the nanoparticles were controlled by the structure and the amount of amphiphilic polymer in the aqueous phase, while the molecular weight of core depended on pH of the continuous phase and the polymerization mechanism (anionic or radical). The evolution of the molecular weight of the synthesized poly(butyl cyanoacrylate) was followed as a function of time at pH 7.4 by size exclusion chromatography. As expected, the degradation kinetics depended on the polymerization mechanism. Finally, a model compound, pyrene, was encapsulated in the synthesized nanoparticles. Its release was found to depend on the conditions of nanoparticles synthesis, especially on the polymerization mechanism.
This paper references
10.1016/J.COLSURFA.2007.05.025
From polymeric surfactants to colloidal systems: 4. Neutral and anionic amphiphilic polysaccharides for miniemulsion stabilization and polymerization
E. Marie (2007)
10.1016/S0165-0270(01)00450-2
PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
P. Calvo (2001)
10.1021/LA001701C
Surface Properties of Polystyrene Nanoparticles Coated with Dextrans and Dextran−PEO Copolymers. Effect of Polymer Architecture on Protein Adsorption
A. D. S. Delgado (2001)
10.1016/S0142-9612(01)00030-8
Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
G. Fontana (2001)
10.1016/J.IJPHARM.2007.01.052
Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion.
C. Huang (2007)
10.1016/S0927-7765(03)00152-8
Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres
C. Rouzes (2003)
10.1016/J.BIOMATERIALS.2005.04.041
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
C. Lemarchand (2006)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1021/BM015634S
Synthesis of chitosan-stabilized polymer dispersions, capsules, and chitosan grafting products via miniemulsion.
E. Marie (2002)
10.1080/02652040600788080
Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model
Alessandra Ambruosi (2006)
10.1023/A:1011973625803
Pegylated Nanoparticles from a Novel Methoxypolyethylene Glycol Cyanoacrylate-Hexadecyl Cyanoacrylate Amphiphilic Copolymer
M. Peracchia (2004)
10.1016/S0142-9612(00)00286-6
Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation.
N. Behan (2001)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1016/J.EJPB.2005.02.009
Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography.
A. Bootz (2005)
10.1016/0168-3659(91)90040-K
Nanoparticle-based dmg delivery systems
J. Kreuter (1991)
10.2174/1573413052953110
Nanosystems in Drug Targeting: Opportunities and Challenges
Jaspreet K. Vasir (2005)
10.1006/JCIS.2002.8357
Surface activity and emulsification properties of hydrophobically modified dextrans.
C. Rouzes (2002)
10.1021/MA061865L
A Route to Nonfunctionalized and Functionalized Poly(n-butylcyanoacrylate) Nanoparticles: Preparation in Miniemulsion
C. Weiss (2007)
10.1007/s11095-006-0284-8
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
10.1016/S0168-3659(99)00063-2
Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
M. Peracchia (1999)
10.1080/10611860500411043
Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats
Alessandra Ambruosi (2005)
10.1007/S003960050218
Modified Booth equation for the calculation of zeta potential
S. R. Deshiikan (1998)
10.1021/MA0257402
Anionic Polymerization of n-Butyl Cyanoacrylate in Emulsion and Miniemulsion
Cédric Limouzin (2003)
10.1016/J.BIOMATERIALS.2006.03.039
Parameters influencing the stealthiness of colloidal drug delivery systems.
A. Vonarbourg (2006)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1016/0378-5173(93)90075-Q
Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate
M. Gallardo (1993)
10.1021/MA961453K
Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology‡
M. Peracchia (1997)
10.1002/MARC.1996.030170404
Novel sub‐ceiling temperature rapid depolymerization‐repolymerization reactions of cyanoacrylate polymers
B. Ryan (1996)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar